Since BioVac has been waiting 22 months to obtain approval for its BCG cancer vaccine, are we to understand, from the answer provided by the minister, that the Department of Health does not consider the vaccine an acceptable drug to be marketed?
Puisque Bio Vac attend depuis 22 longs mois l'homologation de son vaccin BCG-cancer, doit-on comprendre de la réponse de la ministre que ce vaccin n'est pas considéré comme acceptable par le ministère de la Santé pour des fins de commercialisation?